Purpose: To evaluate the potential of photodynamic therapy (PDT) using
benzoporphyrin derivative (BPD) for occlusion of subretinal neovascul
ar membranes, the authors studied efficiency and collateral damage of
PDT-induced photothrombosis in the rabbit choriocapillary layer. Metho
d: Benzoporphyrin derivative, a new photosensitizer, currently in clin
ical trials for tumor therapy, was used. Low-density lipoprotein serve
d as a carrier to enhance selective targeting of vascular endothelial
cells. Results: Complete choriocapillary occlusion was achieved at a B
PD dose of 2 mg/kg and a radiant exposure as low as 10 J/cm(2). When P
DT was performed 3 hours after BPD application, damage to the neural r
etina was minimal. Only inner photoreceptor segments showed mitochondr
ial swelling probably secondary to choroidal ischemia. Bruch's membran
e remained intact. Retinal pigment epithelium was invariably damaged a
s seen with other photosensitizers. Conclusion: Compared with photocoa
gulation BPD-PDT allows endothelial-bound intraluminal photothrombosis
, sparing important structures such as neural retina and Bruch's membr
ane. It,may thus provide a more selective treatment of juxtafoveal and
subfoveal neovascular membranes.